AU2018217352A1 - Improved method for epigenetic immune cell counting - Google Patents
Improved method for epigenetic immune cell counting Download PDFInfo
- Publication number
- AU2018217352A1 AU2018217352A1 AU2018217352A AU2018217352A AU2018217352A1 AU 2018217352 A1 AU2018217352 A1 AU 2018217352A1 AU 2018217352 A AU2018217352 A AU 2018217352A AU 2018217352 A AU2018217352 A AU 2018217352A AU 2018217352 A1 AU2018217352 A1 AU 2018217352A1
- Authority
- AU
- Australia
- Prior art keywords
- blood
- cells
- cell
- nucleic acid
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17155496.7A EP3360971B1 (en) | 2017-02-09 | 2017-02-09 | IMPROVED METHOD FOR COUNTING EPIGENETIC IMMUNE CELLS |
| EP17155496.7 | 2017-02-09 | ||
| PCT/EP2018/053206 WO2018146209A1 (en) | 2017-02-09 | 2018-02-08 | Improved method for epigenetic immune cell counting |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2018217352A1 true AU2018217352A1 (en) | 2019-08-08 |
Family
ID=58016595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2018217352A Abandoned AU2018217352A1 (en) | 2017-02-09 | 2018-02-08 | Improved method for epigenetic immune cell counting |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11319581B2 (cg-RX-API-DMAC10.html) |
| EP (2) | EP3360971B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2020505938A (cg-RX-API-DMAC10.html) |
| CN (1) | CN110382713A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2018217352A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3051314A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2018146209A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102018116353B4 (de) * | 2018-07-05 | 2020-06-10 | Epiontis Gmbh | Verfahren zum Nachweis und zur Zählung epigenetischer Immunzellen in humanen Blutproben für Immundiagnostik und Neugeborenen-Screening |
| JP2025532196A (ja) * | 2022-09-27 | 2025-09-29 | ガーダント ヘルス， インコーポレイテッド | 免疫細胞ｄｎａを定量するための方法 |
| CN119372296B (zh) * | 2024-12-24 | 2025-06-13 | 北京致谱医学检验实验室有限公司 | 基于基因甲基化检测实现人b淋巴细胞计数的试剂盒 |
| CN119372341B (zh) * | 2024-12-30 | 2025-04-11 | 北京致谱医学检验实验室有限公司 | 基于基因甲基化检测实现人nk淋巴细胞计数的试剂盒 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101708544B1 (ko) * | 2005-04-15 | 2017-02-20 | 에피제노믹스 아게 | 세포 증식 질환을 분석하기 위한 방법 및 핵산 |
| DK2199411T3 (en) * | 2008-12-16 | 2015-08-03 | Epiontis Gmbh | Epigenetic markers for the identification of CD3-positive T lymphocytes |
| WO2013135454A1 (en) * | 2012-03-12 | 2013-09-19 | Epiontis Gmbh | Epigenetic marker for the identification of cd3cd4 positive t lymphocytes |
| CN103031372A (zh) * | 2012-08-10 | 2013-04-10 | 深圳先进技术研究院 | Znf545基因甲基化定量检测方法 |
| GB201221133D0 (en) * | 2012-11-23 | 2013-01-09 | Epiontis Gmbh | Epigenetic method for the identification of subpopulations of CD8 and T lympocytes, in particular CD8 alpha and beta T lymphocytes |
| EP2986735B1 (en) * | 2013-04-19 | 2019-03-06 | Epiontis GmbH | Method for identifying the quantitative composition of blood cells in a sample |
-
2017
- 2017-02-09 EP EP17155496.7A patent/EP3360971B1/en active Active
-
2018
- 2018-02-08 CA CA3051314A patent/CA3051314A1/en active Pending
- 2018-02-08 US US16/484,246 patent/US11319581B2/en active Active
- 2018-02-08 WO PCT/EP2018/053206 patent/WO2018146209A1/en not_active Ceased
- 2018-02-08 AU AU2018217352A patent/AU2018217352A1/en not_active Abandoned
- 2018-02-08 JP JP2019542675A patent/JP2020505938A/ja active Pending
- 2018-02-08 CN CN201880010392.6A patent/CN110382713A/zh not_active Withdrawn
- 2018-02-08 EP EP18702740.4A patent/EP3580358B8/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20190390263A1 (en) | 2019-12-26 |
| CA3051314A1 (en) | 2018-08-16 |
| EP3580358A1 (en) | 2019-12-18 |
| EP3360971B1 (en) | 2026-05-20 |
| US11319581B2 (en) | 2022-05-03 |
| WO2018146209A1 (en) | 2018-08-16 |
| EP3580358B8 (en) | 2026-07-08 |
| EP3360971A1 (en) | 2018-08-15 |
| CN110382713A (zh) | 2019-10-25 |
| EP3580358B1 (en) | 2026-05-20 |
| JP2020505938A (ja) | 2020-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Angulo et al. | A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry | |
| US11319581B2 (en) | Method for epigenetic immune cell counting | |
| JP2019162102A (ja) | 末梢血中で、がんによって変化したｒｎａを検出するシステムおよび方法 | |
| Guo et al. | Detection of plasma EGFR mutations in NSCLC patients with a validated ddPCR lung cfDNA assay | |
| US20140272979A1 (en) | Fetal chromosomal aneuploidy diagnosis | |
| Herreros-Villanueva et al. | KRAS mutations: analytical considerations | |
| US10329627B1 (en) | Method for predicting and monitoring response to an immune checkpoint inhibitor | |
| EP2986735A2 (en) | Method for identifying the quantitative cellular composition in a biological sample | |
| Cankovic et al. | Clinical performance of JAK2 V617F mutation detection assays in a molecular diagnostics laboratory: evaluation of screening and quantitation methods | |
| Liu et al. | Laboratory-developed droplet digital PCR assay for quantification of the JAK2V617F mutation | |
| Brow et al. | Assessment of chimerism by next generation sequencing: a comparison to STR/qPCR methods | |
| US20220364187A1 (en) | Detecting, predicting severity of, and/or predicting treatment response to respiratory virus infection | |
| Li et al. | The 1357 bp deletion in β-thalassemia: molecular profiling and hematological characterization in a Guangxi cohort | |
| US12006546B2 (en) | Method for epigenetic immune cell detection and counting in human blood samples | |
| US20210040564A1 (en) | Method for predicting and monitoring response to an immune checkpoint inhibitor | |
| McCafferty et al. | A novel next-generation sequencing capture-based strategy to report somatic hypermutation status using genomic regions downstream to immunoglobulin rearrangements | |
| HK1259669A1 (en) | Improved method for epigenetic immune cell counting | |
| EP4269614B1 (en) | Method for detecting copy number of specific nucleic acid per single cell | |
| EP3818179B1 (en) | Epigenetic method to detect and distinguish ipex and ipex-like syndromes, in particular in newborns | |
| Zheng et al. | Quantification of JAK2V617F mutation load by droplet digital PCR can aid in diagnosis of myeloproliferative neoplasms | |
| CN119372341B (zh) | 基于基因甲基化检测实现人nk淋巴细胞计数的试剂盒 | |
| CN119242823B (zh) | 基于基因甲基化检测实现人t淋巴细胞计数的试剂盒 | |
| Rattarittamrong et al. | Calreticulin mutation analysis in non-mutated Janus kinase 2 essential thrombocythemia patients in Chiang Mai University: analysis of three methods and clinical correlations | |
| Van Paemel et al. | Minimally invasive classification of pediatric solid tumors using reduced representation bisulfite sequencing of cell-free DNA: a proof-of-principle study | |
| KR102036220B1 (ko) | 만성신장질환 특이적 후성학적 메틸화 마커 검출용 조성물 및 검출방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HB | Alteration of name in register |
Owner name: PRECISION FOR MEDICINE GMBH Free format text: FORMER NAME(S): EPIONTIS GMBH |
|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |